Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 478.78% and ...

New FDA draft guidance for drugmakers focuses on trial design for developing obesity treatments. Read more here.

The startup, which has already raised more than half a billion dollars, released Phase 2 results that could position its drug ...

Investing.com - Novo Nordisk (CSE: NOVOb ) remains the "most exciting growth story" in the European pharmaceutical sector and ...

The New York company is hoping to enter the GLP-1RA space with its newest offering requiring dosing every month over ...

Given that more than 40% of Indian adults are struggling with obesity and diabetes, affordable weight-loss drugs are expected ...

By comparison, the FDA-approved drug liraglutide only resulted in just under 6% weight loss after 26 weeks, the researchers found. Common adverse side effects from the drugs included nausea, vomiting, ...

Experimental weight-loss drug Retatrutide shows promise, helping obese adults lose up to 22% of their weight in 48 weeks.

A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?

At least four analysts weighed in on the prospects for Europe’s second-largest company, Novo Nordisk, after the Danish drugmaker reported disappointing results for its next-generation weight-loss drug ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

The epicentre was around 80 km north of Mount Everest, the world's highest mountain and a popular destination for climbers and trekkers. Asia Pacificcategory Tremors in earthquake-prone Tibet 12: ...